HealthQuill Articles by: HealthQuill
Displacement caused by an internal conflict between the government and armed militants, weather extremes, and funding cuts is driving 10 million people in Ethiopia to malnutrition and hunger, a UN agency says.
Climate Drugs Health

Internal strife, funding cuts driving Ethiopians to hunger

HQ Team April 23, 2025: Displacement caused by an internal conflict between the government and armed militants, weather extremes, and funding cuts is

Read More
Swiss healthcare multinational F. Hoffmann-La Roche AG will invest $50 billion in the US over the next five years to expand its research and manufacturing facilities.
Drugs Medical Pharma

Roche to invest $50 billion in US over next five years to expand capacity

HQ Team April 22, 2025: Swiss healthcare multinational F. Hoffmann-La Roche AG will invest $50 billion in the US over the next five

Read More
Marvin Lee Minsky, an American cognitive and computer scientist who co-founded the Massachusetts Institute of Technology's AI laboratory and wrote extensively about AI and philosophy, suggested as early as 1985 that “AI should possess emotions.” Today, emotional AI has evolved beyond academic boundaries, and para-social relationships have become normal. 
Health Opinion Research

AI & the Heart: How Machines Are Replacing Human Connection

April 22, 2025: In a world increasingly run by algorithms, it’s not just playlists or grocery orders—your feelings might be next.  From digital

Read More
Generic drugs made in India, which account for 93% of such medicines made from emerging countries, are linked to hospitalisation, disability and in a few cases death, compared to the US, according to a study by the Ohio State University.
Drugs Health Research

Generic Indian drugs have a 54% higher risk compared to US

HQ Team April 18, 2025: Generic drugs made in India, which account for 93% of such medicines made from emerging countries, are linked

Read More
Britain’s Medicines and Healthcare products Regulatory Agency has authorised GSK Plc’s combination drug to treat patients with multiple myeloma who have received at least one prior therapy.
Drugs Health Pharma

Britain gives green light for GSK Plc’s treatment of rare blood cancer

HQ Team April 18, 2025: Britain’s Medicines and Healthcare products Regulatory Agency has authorised GSK Plc’s combination drug to treat patients with multiple

Read More
Stem cell therapies, which replace dead cells in the brain, can stop movement problems, rigidity and tremors in patients, two small trial studies show.
Drugs Health Research

Stem cell therapy revives hope for patients with Parkinson’s disease

HQ Team April 17, 2025: Stem cell therapies, which replace dead cells in the brain, can stop movement problems, rigidity and tremors in

Read More
Escalating hostilities and limited access to medical supplies are exacerbating an already dire humanitarian crisis in Gaza depriving civilians of shelter, food and medicine, the UN warns.
Drugs Health Medical

Dire humanitarian crisis engulfs Gaza Strip, displaced people swell: UN 

HQ Team April 17, 2025: Escalating hostilities and limited access to medical supplies are exacerbating an already dire humanitarian crisis in Gaza depriving

Read More
Sanofi S.A.’s drug, at its highest dose, has failed to meet its targeted reduction in the yearly rate of worsening episodes in adults with moderate-to-severe asthma, according to a statement.
Drugs Health Pharma

Sanofi’s test drug to treat moderate-to-severe asthma fails to meet goals 

HQ Team April 17, 2025: Sanofi S.A.’s drug, at its highest dose, has failed to meet its targeted reduction in the yearly rate

Read More
Austria’s Cyprumed GmbH has announced a license and option agreement with Merck & Co., to develop oral formulations of the US-based company’s peptides for an upfront payment of $493 million.
Drugs Health Medical

Austria’s Cyprumed in $493 million pact with Merck to develop peptides

HQ Team April 17, 2025: Austria’s Cyprumed GmbH has announced a license and option agreement with Merck & Co., to develop oral formulations

Read More
An oral antibiotic, gepotidacin, has shown efficacy in fighting gonorrhoea — one of the most prevalent sexually transmitted infections in the world, according to the results of an end-stage study published in The Lancet.
Drugs Health Research

Oral antibiotic shows efficacy in end-stage trials to treat gonorrhoea

HQ Team April 16, 2025: An oral antibiotic, gepotidacin, has shown efficacy in fighting gonorrhoea — one of the most prevalent sexually transmitted

Read More